News & Articles

New artifical intelligence algorithm could be the future of drug delivery

Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system

The eCHO™ Medium is ideal for the manufacture of recombinant proteins for medical use, including monoclonal antibodies and complex glycoproteins

Rigaku is presenting its XRD and XRF technology for qualitative and quantitative analysis at the 2019 Eastern Analytical Symposium (EAS)

LG Chem selects second and third drug targets following rapid progress in first program

Sartorius Intellicyt addresses challenges such as high cost and purification difficulties and presents possible solutions

Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers

Polymer chemists can now perform analyses on a single system that conventionally required multiple instruments and retrofitting

Bio-Rad launches iQ-check real-time PCR kit for detection of Aspergillus in cannabis and cannabis-infused products

Addressing the challenges of daily food quality control inspections

Multiplexed immunofluorescence and next-generation image analysis offer spatial insights into the tumor microenvironment

Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago

Watch this webinar to discover the innovation taking place within the FTIR spectroscopy field, leading to novel capabilities for a wide variety of industry applications

Newly discovered antibodies promise significant improvement over current therapies

Thermo Fisher Scientific Orbitrap GC-MS technology to be integrated into Breath Biopsy to support identification of novel biomarkers for early disease detection

Dr. Angela Smirnova discusses her work on microbial ecology, including how the concept of ‘bioremediation’ could help to tackle greenhouse gas emissions with microbes

Watch this webinar to find out how to automate your NGS workflow for cancer diagnostics and personalized medicine

Envigo enters CRISPR gene-edited research model field with the addition of Horizon’s business

Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)